en

PRODUCT DETAIL

ROPINSTAD retard 8 mg

Code 4094A
MA number 27/0040/13-S
Product Form: tbl plg 84x8 mg (blis.PVC/PCTFE/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 27 - ANTIPARKINSONICA
ATC:
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BC Dopamine agonists
N04BC04 Ropinirole
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 06.02.2013
Pediatric posology: Yes
SPC: SPC_ROPINSTAD retard_09.2020.docx  
PIL: PIL_ROPINSTAD retard_09.2020.docx  
Safety feature Yes
Data update: 21.08.2018
eu-flag.png sk-flag.png